Bexsero is indicated for active immunisation of individuals from 2 months of age and older against invasive meningococcal disease caused by Neisseria meningitidis group B.
The use of this vaccine should be in line with official recommendations.
Bexsero can be given concomitantly with any of the following vaccine antigens, either as monovalent or as combination vaccines 1:
— Meningococcal groups A, C, W, Y conjugate
— Diphtheria, tetanus, acellular pertussis, inactivated polio
— Haemophilus influenzae type b
— Hepatitis B
— Heptavalent pneumococcal conjugate
— Measles, mumps, rubella
- Bexsero Summary of Product Characteristics. Available from:https://www.medicines.ie/medicines/bexsero-suspension-for-injection-in-pre-filled-syringe-31445/ Last accessed – August 2020
- HSE Immunisation Guidelines. Available from: https://www.hse.ie/eng/health/immunisation/hcpinfo/guidelines/chapter13.pdf, accessed: August 2020